Metastatic Renal Cell Carcinoma: Safety and Efficacy of Available Treatment Options and Considerations for Patient Management - Episode 7

Prognostic Value of Biomarkers in RCC

Robert Alter, MD opines on the current prognostic value of biomarkers for RCC and the need for additional data in the field.